Veterinary Medicines

Equip FT Injektionssuspension für Pferde und Ponys

Authorised
  • Tetanus toxoid
  • Influenza A virus, subtype H3N8, strain A/equine/Kentucky/1/98, Inactivated
  • Influenza A virus, subtype H7N7, strain A/equine/Newmarket/77, Inactivated
  • Influenza A virus, subtype H3N8, strain A/equine/Borlange/91, Inactivated
Download as PDF

Product identification

Medicine name:
Equip FT Injektionssuspension für Pferde und Ponys
Active substance:
  • Tetanus toxoid
  • Influenza A virus, subtype H3N8, strain A/equine/Kentucky/1/98, Inactivated
  • Influenza A virus, subtype H7N7, strain A/equine/Newmarket/77, Inactivated
  • Influenza A virus, subtype H3N8, strain A/equine/Borlange/91, Inactivated
Target species:
  • Horse
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Tetanus toxoid
    70.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Influenza A virus, subtype H3N8, strain A/equine/Kentucky/1/98, Inactivated
    2.64
    log10 haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
  • Influenza A virus, subtype H7N7, strain A/equine/Newmarket/77, Inactivated
    1.20
    log10 haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
  • Influenza A virus, subtype H3N8, strain A/equine/Borlange/91, Inactivated
    2.35
    log10 haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.02825.01.1
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 31/10/2025
Download